Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,343 Added 0.29% |
$190,290
$30.0 p/Share
|
Nov 06
2017 |
|
QCOM
|
Matthew S Grob
EVP, Technology |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$128,820
$64.41 p/Share
|
Nov 06
2017 |
|
QCOM
|
Matthew S Grob
EVP, Technology |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 50.0% |
$82,720
$41.36 p/Share
|
Nov 06
2017 |
|
PLXS
|
Dean A Foate
Director |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 4.64% |
$850,500
$60.75 p/Share
|
Nov 06
2017 |
|
PLXS
|
Dean A Foate
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 14,000 Added 4.43% |
$479,080
$34.22 p/Share
|
Nov 06
2017 |
|
ALNA
|
Third Rock Ventures Ii, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 215,000 Added 7.15% |
$3,010,000
$14.0 p/Share
|
Nov 06
2017 |
|
ALNA
|
Third Rock Ventures Ii, L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,575,964 Added 50.0% |
-
|
Nov 06
2017 |
|
HQY
|
Berkley Capital, LLC |
SELL
Open market or private sale
|
Indirect | 373,500 Reduced 1.37% |
$19,732,006
$52.83 p/Share
|
Nov 06
2017 |
|
VIRX
|
Mpm Oncology Impact Management Gp LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 16,200 Added 0.48% |
$44,874
$2.77 p/Share
|
Nov 06
2017 |
|
ESL
|
First Pacific Advisors, LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,589 Reduced 0.73% |
$1,766,885
$95.05 p/Share
|
Nov 06
2017 |
|
TXN
|
R Gregory Delagi
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 122,500 Reduced 47.71% |
$12,036,850
$98.26 p/Share
|
Nov 06
2017 |
|
TXN
|
R Gregory Delagi
Sr. Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 122,500 Added 32.3% |
$2,823,625
$23.05 p/Share
|
Nov 06
2017 |
|
EVRI
|
Michael D Rumbolz
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 445 Reduced 0.42% |
$3,729
$8.38 p/Share
|
Nov 05
2017 |
|
TMP
|
Stephen S Romaine
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 266 Reduced 0.74% |
$22,663
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
Scott L Gruber
EVP, Pres & CEO, VIST Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 74 Reduced 0.97% |
$6,305
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
Susan M. Valenti
EVP, Corporate Marketing |
SELL
Payment of exercise price or tax liability
|
Direct | 84 Reduced 0.89% |
$7,157
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
David S Boyce
EVP, Pres. & CEO Tompkins Ins. |
SELL
Payment of exercise price or tax liability
|
Direct | 103 Reduced 0.49% |
$8,776
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
John M Mc Kenna
EVP, Pres. Tompkins Comm. Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 84 Reduced 1.08% |
$7,157
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
Francis M Fetsko
EVP, COO, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 84 Reduced 0.65% |
$7,157
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
Gregory J Hartz
EVP, Pres.&CEO Tompkins Trust |
SELL
Payment of exercise price or tax liability
|
Direct | 84 Reduced 0.45% |
$7,157
$85.2 p/Share
|
Nov 04
2017 |
|
TMP
|
Gerald J Klein Jr
EVP Pres&CEO Mahopac Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 84 Reduced 0.41% |
$7,157
$85.2 p/Share
|
Nov 04
2017 |
|
PG
|
Steven D Bishop
CEO - Health Care |
SELL
Bona fide gift
|
Direct | 2,623 Reduced 5.55% |
-
|
Nov 03
2017 |
|
PG
|
Steven D Bishop
CEO - Health Care |
BUY
Bona fide gift
|
Indirect | 322 Added 16.0% |
-
|
Nov 03
2017 |
|
NIC
|
Thomas L Herlache
Director |
SELL
Open market or private sale
|
Indirect | 1,640 Reduced 25.01% |
$92,463
$56.38 p/Share
|
Nov 03
2017 |
|
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 22,759 Reduced 0.47% |
$434,697
$19.1 p/Share
|
Nov 03
2017 |
|
LLY
|
Susan Mahony
SVP & Pres., Lilly Oncology |
SELL
Bona fide gift
|
Direct | 15,861 Reduced 28.9% |
-
|
Nov 03
2017 |
|
BEN
|
Craig Steven Tyle
EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 11,707 Added 8.03% |
$500,943
$42.79 p/Share
|
Nov 03
2017 |
|
BEN
|
Jennifer M Johnson
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 45,180 Added 2.83% |
$966,852
$21.4 p/Share
|
Nov 03
2017 |
|
BEN
|
Gregory E Johnson
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 68,942 Added 3.16% |
$2,950,028
$42.79 p/Share
|
Nov 03
2017 |
|
BEN
|
Alok Sethi
EVP, Head of Global Operations |
BUY
Grant, award, or other acquisition
|
Direct | 6,312 Added 15.51% |
$135,077
$21.4 p/Share
|
Nov 03
2017 |
|
BEN
|
Kenneth A Lewis
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 18,155 Added 11.89% |
$776,852
$42.79 p/Share
|
Nov 03
2017 |
|
SHAK
|
Select Equity Group, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 45,861 Reduced 4.04% |
$1,676,678
$36.56 p/Share
|
Nov 03
2017 |
|
SHAK
|
Select Equity Group, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,769 Reduced 2.94% |
$176,024
$36.91 p/Share
|
Nov 03
2017 |
|
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 14,749 Added 0.68% |
$431,556
$29.26 p/Share
|
Nov 03
2017 |
|
HLI
|
Orix Hlhz Holding LLC |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 22.19% |
$5,202,500
$41.62 p/Share
|
Nov 03
2017 |
|
EFSC
|
Michael T Normile
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 229 Added 50.0% |
-
|
Nov 03
2017 |
|
GL
|
Michael Clay Majors
EVP - Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 24.47% |
$256,320
$85.44 p/Share
|
Nov 03
2017 |
|
GL
|
Michael Clay Majors
EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 19.66% |
$160,830
$53.61 p/Share
|
Nov 03
2017 |
|
GL
|
John Henry Rogers Jr |
SELL
Open market or private sale
|
Direct | 1,875 Reduced 100.0% |
$159,938
$85.3 p/Share
|
Nov 03
2017 |
|
GL
|
John Henry Rogers Jr |
BUY
Exercise of conversion of derivative security
|
Direct | 1,875 Added 50.0% |
$100,519
$53.61 p/Share
|
Nov 03
2017 |
|
GL
|
Carol A Mccoy |
SELL
Open market or private sale
|
Direct | 20,250 Reduced 17.56% |
$1,728,743
$85.37 p/Share
|
Nov 03
2017 |
|
GL
|
Carol A Mccoy |
BUY
Exercise of conversion of derivative security
|
Direct | 20,250 Added 14.94% |
$599,198
$29.59 p/Share
|
Nov 03
2017 |
|
TMP
|
Gregory J Hartz
EVP, Pres.&CEO Tompkins Trust |
SELL
Payment of exercise price or tax liability
|
Direct | 1,413 Reduced 7.03% |
$120,388
$85.2 p/Share
|
Nov 03
2017 |
|
TMP
|
Gregory J Hartz
EVP, Pres.&CEO Tompkins Trust |
BUY
Exercise of conversion of derivative security
|
Direct | 2,002 Added 9.4% |
$84,625
$42.27 p/Share
|
Nov 03
2017 |
|
HON
|
Krishna Mikkilineni
SrVP, Engineering, Ops & IT |
SELL
Open market or private sale
|
Direct | 13,074 Reduced 12.45% |
$1,897,299
$145.12 p/Share
|
Nov 03
2017 |
|
HON
|
Krishna Mikkilineni
SrVP, Engineering, Ops & IT |
BUY
Exercise of conversion of derivative security
|
Direct | 13,074 Added 11.07% |
$764,568
$58.48 p/Share
|
Nov 03
2017 |
|
SCHW
|
Peter B. Crawford
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 592 Reduced 4.98% |
$26,456
$44.69 p/Share
|
Nov 03
2017 |
|
SCHW
|
Terri R Kallsen
EVP - Investor Services |
SELL
Payment of exercise price or tax liability
|
Direct | 890 Reduced 20.83% |
$39,774
$44.69 p/Share
|
Nov 03
2017 |
|
SCHW
|
David R Garfield
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,712 Reduced 1.92% |
$76,509
$44.69 p/Share
|
Nov 03
2017 |
|
QCOM
|
Matthew S Grob
EVP, Technology |
SELL
Open market or private sale
|
Direct | 18,000 Reduced 100.0% |
$1,080,000
$60.0 p/Share
|
Nov 03
2017 |